# Bayer AG - Inspection Records

Source: https://www.keypedia.com/companies/bayer-ag/c999165f-4c13-4f49-b979-087064975cb0

> Inspection records and compliance data for Bayer AG in North Rhine-Westphalia, 51368. Access full analysis and detailed observations.

---

## Details

- Name: Bayer AG
- FEI Number: 3002806462
- City: North Rhine-Westphalia
- State: 51368
- Country Name: Germany
- Address Line 1: Leverkusen
- Zip Code: Germany
- Facility Type: Parenteral, solid oral dosage, and API drug manufacturer
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [FDA Inspection 1247034 - Bayer AG - 2023-09-07](https://www.keypedia.com/records/fda_inspections/bayer-ag/745504cb-756f-4fe2-a8a1-01c5a1c51700) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 7, 2023
- [FDA Inspection 1209999 - Bayer AG - 2022-05-13](https://www.keypedia.com/records/fda_inspections/bayer-ag/4c012418-6530-43d6-abd3-60cd3c2d8860) — classification: No Action Indicated (NAI), source: FDA, date: May 13, 2022
- [EIR - Bayer AG - 2020-07-27](https://www.keypedia.com/records/eir/bayer-ag/3163d8e3-9c8d-4fcd-9347-cc7c31f69131) — source: FDA, date: July 27, 2020
- [483 - Bayer AG - 2020-07-27](https://www.keypedia.com/records/483/bayer-ag/78f37569-bb65-4bb2-858b-6307d0a03b06) — source: FDA, date: July 27, 2020
- [FDA Inspection 1125538 - Bayer AG - 2020-07-27](https://www.keypedia.com/records/fda_inspections/bayer-ag/6cdbe19f-b1e4-4367-a031-b71895e387b6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 27, 2020
- [EIR - Bayer AG - 2019-03-22](https://www.keypedia.com/records/eir/bayer-ag/ce280f07-ec46-4e54-83e4-6e9965b6eabf) — source: FDA, date: March 22, 2019
- [483 - Bayer AG - 2019-03-22](https://www.keypedia.com/records/483/bayer-ag/9e84a5c7-4f9e-40e6-8562-b1ae8d632e50) — source: FDA, date: March 22, 2019
- [FDA Inspection 1084360 - Bayer AG - 2019-03-22](https://www.keypedia.com/records/fda_inspections/bayer-ag/b9423cc2-a943-45c0-ba8c-4a9adfb46666) — classification: Official Action Indicated (OAI), source: FDA, date: March 22, 2019
- [483 - Bayer AG - 2017-01-20](https://www.keypedia.com/records/483/bayer-ag/a270ee31-f12b-46d7-a84a-fd3708acd9fc) — source: FDA, date: January 20, 2017
- [WARNING_LETTER - Bayer AG - 2017-01-20](https://www.keypedia.com/records/warning_letter/bayer-ag/95954910-8300-48a1-a9ea-e9a9cb4d9ac1) — source: FDA, date: January 20, 2017
- [FDA Inspection 1004195 - Bayer AG - 2017-01-20](https://www.keypedia.com/records/fda_inspections/bayer-ag/c65a5db9-942c-4b9b-a5cf-90ff21e2bf78) — classification: Official Action Indicated (OAI), source: FDA, date: January 20, 2017
- [FDA Inspection 975815 - Bayer AG - 2016-06-03](https://www.keypedia.com/records/fda_inspections/bayer-ag/ff4d59c1-cab1-4da4-9598-1a49e165c137) — classification: No Action Indicated (NAI), source: FDA, date: June 3, 2016
- [FDA Inspection 905879 - Bayer AG - 2014-11-14](https://www.keypedia.com/records/fda_inspections/bayer-ag/bb7d2515-6b6f-41d6-849a-0d9349b769c8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 14, 2014
- [FDA Inspection 791785 - Bayer AG - 2012-07-09](https://www.keypedia.com/records/fda_inspections/bayer-ag/6fe40ce5-ce79-4dfc-bb7d-66026f1c2359) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 9, 2012
- [FDA Inspection 651524 - Bayer AG - 2010-02-23](https://www.keypedia.com/records/fda_inspections/bayer-ag/39b37929-0bbf-4f4c-9c5a-b116271b46a4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 23, 2010

## Related Companies

- [Hamari PFST, Ltd.](https://www.keypedia.com/companies/hamari-pfst-ltd/17548bf6-b8d5-4469-be75-78ca6f0f7bd5)
- [Baxter Oncology GmbH](https://www.keypedia.com/companies/baxter-oncology-gmbh/43dd5bdb-ca73-4678-ba1f-6ef4b5400e06)
- [Sinopep-Allsino Biopharmaceutical Co., Ltd.](https://www.keypedia.com/companies/sinopep-allsino-biopharmaceutical-co-ltd/f45b83cf-0416-4308-92bf-f7f3212ca356)
- [Fujian Genohope Biotech Ltd.](https://www.keypedia.com/companies/fujian-genohope-biotech-ltd/2383a4ad-4fe8-4b52-b528-9b72885e00a9)
- [Suzhou Union Biopharm Co., Ltd.](https://www.keypedia.com/companies/suzhou-union-biopharm-co-ltd/5d9c9c07-1afc-44da-b4ff-872317d01143)
- [Ash Stevens LLC](https://www.keypedia.com/companies/ash-stevens-llc/52224de1-83ac-4289-a4f7-7bc9f6813f03)
- [Boehringer Ingelheim Fremont, Inc.](https://www.keypedia.com/companies/boehringer-ingelheim-fremont-inc/3d7d0ca7-27cd-4223-8ade-7193417c9861)
- [Sumitomo Dainippon Pharma Co., Ltd.](https://www.keypedia.com/companies/sumitomo-dainippon-pharma-co-ltd/40ead027-5fd5-4deb-a37b-40301cffd612)
- [Cipla, Ltd.](https://www.keypedia.com/companies/cipla-ltd/f726d9c8-4fe7-456e-848c-f9ef86f00e4f)
- [Bristol-Myers Squibb Company](https://www.keypedia.com/companies/bristol-myers-squibb-company/3734a119-014f-49c6-b518-fc8b1dea7f92)

## Related Officers

- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [Director](https://www.keypedia.com/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)
- [Investigator](https://www.keypedia.com/people/noreen-muniz/0bb20d12-62ad-42aa-8b0a-c44b339d413f)
- [Consumer Safety Officer (Drug Specialist)](https://www.keypedia.com/people/alan-p-kurtzberg/36ee316e-6d19-44b2-a131-fc254ada4f41)